<?xml version="1.0"?>
<!--<!DOCTYPE nitf SYSTEM "nitf-3-4.dtd">-->
<nitf>
  <head>
    <title id="Title"></title>
    <docdata management-doc-idref="">
      <date.issue id="CreationDate" norm="" />
      <du-key id="rev-ver" generation="1" version="Default" />
      <du-key id="Parent-Version" version="" />
      <identified-content>
        <classifier id="newspro-nitf" value="r2" />
        <classifier id="Newspro-App" value="Epaper" />
        <classifier id="Content-Type" value="Story" />
        <classifier id="storyID" value="72623" />
        <classifier id="CmsConID" value="" />
        <classifier id="Desk" value="" />
        <classifier id="Source" value="" />
        <classifier id="Edition" value="" />
        <classifier id="Category" value="-1" />
        <classifier id="UserName" value="" />
        <classifier id="PublicationDate" value="09/09/2020" />
        <classifier id="PublicationName" value="DailyStar" />
        <classifier id="IsPublished" value="Y" />
        <classifier id="IsPlaced" value="Y" />
        <classifier id="IsCompleated" value="N" />
        <classifier id="IsProofed" value="N" />
        <classifier id="User" value="" />
        <classifier id="Headline-Count" value="" />
        <classifier id="Slug-Count" value="0" />
        <classifier id="Photo-Count" value="0" />
        <classifier id="Caption-Count" value="0" />
        <classifier id="Word-Count" value="0" />
        <classifier id="Character-Count" value="0" />
        <classifier id="Location" value="" />
        <classifier id="TemplateType" value="1" />
        <classifier id="StoryType" value="Story" />
        <classifier id="Author" value="" />
        <classifier id="UOM" value="mm" />
        <classifier id="kicker" value="" />
        <classifier id="ByLine" value="" />
        <classifier id="DateLine" value="" />
        <classifier id="box-geometry" value="509,854,794,1165" />
      </identified-content>
      <urgency id="home-page" ed-urg="0" />
      <urgency id="priority" ed-urg="0" />
      <doc-scope id="scope" value="0" />
    </docdata>
    <pubdata type="print" name="DailyStar" date.publication="20200909T000000+5.30" edition.name="Main Edition" edition.area="MAI" position.section="DST09092006MAI-INTERNATIONAL" position.sequence="6" ex-ref="DST09092006MAI-INTERNATIONAL.indd" />
  </head>
  <body>
<body.head>
      <hedline>
    	<hl1 id="Headline1" class="1" style="Headline1">
		<lang class="3" style="Headline1"  font="Myriad Pro"  size="17">Russian Covid-19 vaccine </lang>
	</hl1>
<hl2 id="Headline1" class="1" style="Headline2">
		<lang class="3" style="Headline2"  font="ITC Giovanni Std"  size="28">First batch produced for public circulation </lang>
	</hl2>

       </hedline>
</body.head>
    <body.content id="Bodytext" CaptionAsBody="0">
     <block>
	<media id="1" media-type="image">
			</media>
</block>

     <p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Bold">The Statesman/ANN
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">In some good news for millions living in hope for a Covid-19 vaccine shot, the Russian Health Ministry yesterday said that the first batch of Sputnik V vaccine has been produced for civilian circulation.
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">The supplies of the medication to the Russian regions are expected soon, the Health Ministry told reporters, reports Tass news agency.
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">“The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests and was produced for civilian circulation. In the near future, the supplies of the first batches of the vaccine to the regions are expected,” the ministry said.
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">Earlier this month, a study published in the peer-reviewed journal The Lancet said a Russian Covid-19 vaccine has shown no serious side effects and elicited an immune response in early human trials.
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">Russia last month registered the “Sputnik V”, becoming the first country to approve a Covid-19 vaccine.
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">Meanwhile, India yesterday said it has received an offer from Russia to conduct a trial and manufacture its “Sputnik-V”, with several Indian companies currently studying the proposal, an official said yesterday.
</lang>
</p>
<p style=".Bodylaser">
	<lang class="3" style=".Bodylaser" font="ITC Giovanni Std" fontStyle="Book">“The government of India attaches great importance to this offer of partnership from a friend,” he added. The outcome of discussions on the offer were expected soon, he added.
</lang>
</p>

    </body.content>
  </body>
</nitf>